EGFR and hepatocellular carcinoma: PSMD9 promotes HCC cell proliferation and metastasis via direct interaction with c-Cbl, subsequently decreasing EGFR ubiquitination and influencing EGFR endosomal trafficking and degradation (Fig. 8K).